The effects of remdesivir on long-term symptoms in patients hospitalised for COVID-19: a pre-specified exploratory analysis

MLA

Thale D. J. Hovdun Patrick-Brown, et al. “The Effects of Remdesivir on Long-Term Symptoms in Patients Hospitalised for COVID-19: A Pre-Specified Exploratory Analysis.” Communications Medicine, vol. 4, no. 1, Nov. 2024, pp. 1–7. EBSCOhost, https://doi.org/10.1038/s43856-024-00650-4.

APA

Thale D. J. Hovdun Patrick-Brown, Andreas Barratt-Due, Marius Trøseid, Anne Ma Dyrhol-Riise, Katerina Nezvalova-Henriksen, Trine Kåsine, Pål Aukrust, Inge C. Olsen, & NOR Solidarity consortium. (2024). The effects of remdesivir on long-term symptoms in patients hospitalised for COVID-19: a pre-specified exploratory analysis. Communications Medicine, 4(1), 1–7. https://doi.org/10.1038/s43856-024-00650-4

Chicago

Thale D. J. Hovdun Patrick-Brown, Andreas Barratt-Due, Marius Trøseid, Anne Ma Dyrhol-Riise, Katerina Nezvalova-Henriksen, Trine Kåsine, Pål Aukrust, Inge C. Olsen, and NOR Solidarity consortium. 2024. “The Effects of Remdesivir on Long-Term Symptoms in Patients Hospitalised for COVID-19: A Pre-Specified Exploratory Analysis.” Communications Medicine 4 (1): 1–7. doi:10.1038/s43856-024-00650-4.